MedPath

OVRETTE TABLETS

OVRETTE TABLETS

Discontinued
DIN Number

02223090

Drug Class

Human

Market Date

N/A

Company
HC

Pfizer Canada Ulc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02223090
AIG Number0106394001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
G03AC PROGESTOGENS
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification68:12.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

NORGESTRELActive
Strength: 0.075 MG
Monograph: NORGESTREL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.